Welcome to the Norwegian Experimental Cell Transplantation homepage
Hanne Scholz Group leader
The research group was established at the Institute of Surgical Research in 2005 and has focused on the development of new strategies to counteract the harmful effects of islet cells before transplantation, and to strengthen islet growth and function after transplantation.
Josifovska N, Niemi EM, Ramalingam M, Manivasagam G, Scholz H, Petrovski G(2025) A pilot study for decellularizing porcine cornea for future use in corneal regeneration PLoS One, 20(12), e0339462 DOI 10.1371/journal.pone.0339462, PubMed 41474796
Carlsson PO, Hu X, Scholz H, Ingvast S, Lundgren T, Scholz T, Eriksson O, Liss P, Yu D, Deuse T, Korsgren O, Schrepfer S(2025) Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression N Engl J Med, 393(9), 887-894 DOI 10.1056/NEJMoa2503822, PubMed 40757665
Waage A, Khan A, Labori KJ, Birkeland KI, Scholz H, Jensen TG, Tholfsen T, Line PD, Hagness M(2024) Implementation of a nationwide program for total pancreatectomy and islet autotransplantation in chronic pancreatitis: A Scandinavian single-center observational study Scand J Surg, 114(2), 174-182 DOI 10.1177/14574969241298985, PubMed 39558154